Abstract Objective Glucocorticoids (GCs) are a cornerstone in treating various common and
uncommon diseases. The aim of this study was to estimate the prevalence of GC use in …

Objective Glucocorticoid treatment of inflammatory disorders is associated with significant
adverse effects related to glucocorticoid excess as well as adrenal insufficiency. This …

Objectives Glucocorticoid (GC) use is widespread and associated with many adverse
effects. Thus, it is important to ascertain GC utilisation patterns. In this study, we examined …

Objective The aim of the study was to investigate all-cause and disease-specific mortality in
a large population-based cohort of oral glucocorticoid (GC) users. Methods This was a …

Methods Data of UK adult patients registered between January 1989 and December 2008
with general practices contributing to The Health Improvement Network (THIN) database …

Objectives To study trends in use of oral glucocorticoids (GCs) among adults, characteristics
of oral GC initiators and prescriptions for the prevention of potential adverse effects …

Background Biochemical adrenal insufficiency induced by glucocorticoid treatment is
prevalent, but data on the clinical implications are sparse. We investigated clinical …

Objectives Lifestyle may affect observed associations between glucocorticoid use and
adverse events. This study aimed to investigate whether lifestyle differ according to use of …

A comprehensive study from Denmark established that the systemic use of glucocorticoids
hormones has an annual prevalence of 3% and has been stable from 1999 to 2014. We …

Background Increased morbidity and mortality associated with conventional glucocorticoid
replacement therapy for primary adrenal insufficiency (primary AI; estimated prevalence 93 …